 |
0 Diseases |  |
70 Trials |
|
70 Trials |  |
3689 News |  |
| «12...70717273747576777879808182» |
- | fluoxetine / Generic mfg.
New P1 trial: Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions (clinicaltrials.gov) - Nov 16, 2016
P1, N=26, Completed, Sponsor: Torrent Pharmaceuticals Limited
- | fluoxetine / Generic mfg.
New P1 trial: Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablets Under Fed Conditions (clinicaltrials.gov) - Nov 16, 2016
P1, N=26, Completed, Sponsor: Torrent Pharmaceuticals Limited
- | Vyvanse (lisdexamfetamine) / Shionogi, Takeda
Trial completion, Enrollment change: Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation (clinicaltrials.gov) - Nov 4, 2016
P2, N=39, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Completed | N=50 --> 39
- |||||| Fetzima (levomilnacipran ER) / Pierre Fabre, AbbVie
Enrollment open, Trial primary completion date: Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder (clinicaltrials.gov) - Oct 28, 2016
P3, N=660, Recruiting, Sponsor: Forest Laboratories
Recruiting --> Completed | N=50 --> 39 Active, not recruiting --> Recruiting | Trial primary completion date: Dec 2018 --> Mar 2018
- fluoxetine / Generic mfg.
Enrollment open: FLUORESCE: Fluoxetine for Visual Recovery After Ischemic Stroke (clinicaltrials.gov) - Oct 27, 2016
P2, N=40, Recruiting, Sponsor: Bogachan Sahin
Active, not recruiting --> Recruiting | Trial primary completion date: Dec 2018 --> Mar 2018 Not yet recruiting --> Recruiting
- New trial: Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder (clinicaltrials.gov) - Oct 14, 2016
P=N/A, N=10000, Active, not recruiting, Sponsor: University Medical Center Groningen
- | fluoxetine / Generic mfg.
Biomarker, New P2 trial: Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI (clinicaltrials.gov) - Oct 11, 2016
P2, N=80, Not yet recruiting, Sponsor: University of Iowa
- | fluoxetine / Generic mfg.
Trial completion: Efficacy of Fluoxetine Against Seizure-induced Central Apneas (clinicaltrials.gov) - Oct 5, 2016
P3, N=70, Completed, Sponsor: Hospices Civils de Lyon
Not yet recruiting --> Recruiting Recruiting --> Completed
- bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
Trial primary completion date: Bupropion for Depression in ESRD Patients on Hemodialysis (clinicaltrials.gov) - Sep 27, 2016
P4, N=40, Recruiting, Sponsor: University of Arkansas
Recruiting --> Completed Trial primary completion date: Aug 2016 --> Aug 2017
- | fluoxetine / Generic mfg.
New P4 trial: Measurement-based Care for Depression in Resource-Poor Settings (clinicaltrials.gov) - Sep 27, 2016
P4, N=140, Active, not recruiting, Sponsor: Florida International University
- fluoxetine / Generic mfg.
Trial primary completion date: Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF. (clinicaltrials.gov) - Sep 14, 2016
P4, N=45, Recruiting, Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Trial primary completion date: Aug 2016 --> Aug 2017 Trial primary completion date: Aug 2016 --> Mar 2017
- Viibryd (vilazodone) / AbbVie
Trial primary completion date: Effects of Treatment on Decision-making in Major Depression (clinicaltrials.gov) - Sep 9, 2016
P4, N=100, Active, not recruiting, Sponsor: Emory University
Trial primary completion date: Aug 2016 --> Mar 2017 Trial primary completion date: Aug 2016 --> Aug 2017
- lithium carbonate ER / Generic mfg.
Trial primary completion date: Prevention of Relapse & Recurrence of Bipolar Depression (clinicaltrials.gov) - Aug 31, 2016
P4, N=200, Active, not recruiting, Sponsor: University of Pennsylvania
Trial primary completion date: Aug 2016 --> Aug 2017 Trial primary completion date: Jun 2015 --> Sep 2016
- venlafaxine / Generic mfg., fluoxetine / Generic mfg.
Trial primary completion date: Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression (clinicaltrials.gov) - Aug 9, 2016
P4, N=200, Recruiting, Sponsor: Capital Medical University
Trial primary completion date: Jun 2015 --> Sep 2016 Trial primary completion date: Sep 2016 --> Jun 2017
- riluzole / Generic mfg., amiloride hydrochloride / Generic mfg., fluoxetine / Generic mfg.
Enrollment closed, P2b data, Trial primary completion date: MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (clinicaltrials.gov) - Jul 14, 2016
P2b, N=445, Active, not recruiting, Sponsor: University College, London
Trial primary completion date: Sep 2016 --> Jun 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2018 --> Jul 2018
- fluoxetine / Generic mfg.
Trial completion, HEOR, Metastases: Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer (clinicaltrials.gov) - Jul 6, 2016
P2, N=21, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2018 --> Jul 2018 Terminated --> Completed
- ||||| Fetzima (levomilnacipran ER) / Pierre Fabre, AbbVie
Enrollment closed, Trial primary completion date: Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder (clinicaltrials.gov) - Jun 19, 2016
P3, N=660, Active, not recruiting, Sponsor: Forest Laboratories
Terminated --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2018 --> Dec 2018
- fluoxetine / Generic mfg.
Trial completion, Trial primary completion date: PTAD GIA: An Adaptive Treatment Strategy for Adolescent Depression-Continuation (clinicaltrials.gov) - Jun 14, 2016
P1/2, N=45, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2018 --> Dec 2018 Recruiting --> Completed | Trial primary completion date: Nov 2016 --> Jun 2016
- fluoxetine / Generic mfg.
Trial completion, Trial primary completion date: PTAD: An Adaptive Treatment Strategy for Adolescent Depression (clinicaltrials.gov) - Jun 14, 2016
P1/2, N=45, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Completed | Trial primary completion date: Nov 2016 --> Jun 2016 Recruiting --> Completed | Trial primary completion date: Nov 2016 --> Jun 2016
- |||||| Trintellix (vortioxetine) / Lundbeck, Takeda
Enrollment open: Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD) (clinicaltrials.gov) - Jun 10, 2016
P3, N=750, Recruiting, Sponsor: H. Lundbeck A/S
Recruiting --> Completed | Trial primary completion date: Nov 2016 --> Jun 2016 Not yet recruiting --> Recruiting
- fluoxetine / Generic mfg.
Trial primary completion date: Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM) (clinicaltrials.gov) - May 26, 2016
P=N/A, N=64, Recruiting, Sponsor: University of Maryland
Not yet recruiting --> Recruiting Trial primary completion date: Jul 2016 --> Dec 2016
- | fluoxetine / Generic mfg.
Enrollment open: STEP: The Staged Treatment in Early Psychosis Study (clinicaltrials.gov) - May 26, 2016
P3, N=500, Recruiting, Sponsor: Orygen Youth Health Research Centre
Trial primary completion date: Jul 2016 --> Dec 2016 Not yet recruiting --> Recruiting
- |||||| Trintellix (vortioxetine) / Lundbeck, Takeda
Enrollment open: Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) (clinicaltrials.gov) - May 23, 2016
P3, N=750, Recruiting, Sponsor: H. Lundbeck A/S
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- fluoxetine / Generic mfg.
Enrollment open: Acupuncture for Ischemic Post-stroke Depression (clinicaltrials.gov) - May 19, 2016
P=N/A, N=208, Recruiting, Sponsor: Menghan Li
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | fluoxetine / Generic mfg.
New P4 trial: RECONISE: Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke (clinicaltrials.gov) - May 11, 2016
P4, N=60, Recruiting, Sponsor: University Hospital, Toulouse
- || fluoxetine / Generic mfg.
New P3 trial: STEP: The Staged Treatment in Early Psychosis Study (clinicaltrials.gov) - Apr 26, 2016
P3, N=500, Not yet recruiting, Sponsor: Orygen Youth Health Research Centre
- Trial primary completion date: Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients (clinicaltrials.gov) - Apr 21, 2016
P4, N=60, Recruiting, Sponsor: Shanghai Mental Health Center
Not yet recruiting --> Recruiting Trial primary completion date: Feb 2016 --> Jun 2017
- fluoxetine / Generic mfg.
Trial primary completion date: Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients (clinicaltrials.gov) - Apr 19, 2016
P2, N=45, Recruiting, Sponsor: Spaulding Rehabilitation Hospital
Trial primary completion date: Feb 2016 --> Jun 2017 Trial primary completion date: Oct 2016 --> Oct 2017
- fluoxetine / Generic mfg.
New P2 trial: FLUORESCE: Fluoxetine for Visual Recovery After Ischemic Stroke (clinicaltrials.gov) - Apr 14, 2016
P2, N=40, Not yet recruiting, Sponsor: Bogachan Sahin
- fluoxetine / Generic mfg.
Biomarker, Enrollment open, HEOR: FLAME: 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression (clinicaltrials.gov) - Apr 13, 2016
P4, N=400, Recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Oct 2016 --> Oct 2017 Active, not recruiting --> Recruiting
- fluoxetine / Generic mfg.
Trial primary completion date: Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? (clinicaltrials.gov) - Apr 11, 2016
P3, N=300, Recruiting, Sponsor: Cairo University
Active, not recruiting --> Recruiting Trial primary completion date: Sep 2016 --> Sep 2017
- | flupentixol/melitracen / Generic mfg., fluoxetine / Generic mfg.
New P1/2 trial: Hierarchical Treatment Based on Somatization Symptom Checklist (clinicaltrials.gov) - Mar 31, 2016
P1/2, N=200, Recruiting, Sponsor: RenJi Hospital
- fluoxetine / Generic mfg.
Trial primary completion date: PTAD GIA: An Adaptive Treatment Strategy for Adolescent Depression-Continuation (clinicaltrials.gov) - Mar 19, 2016
P1/2, N=45, Recruiting, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Trial primary completion date: Sep 2016 --> Sep 2017 Trial primary completion date: Feb 2016 --> Nov 2016
- fluoxetine / Generic mfg.
Trial primary completion date: PTAD: An Adaptive Treatment Strategy for Adolescent Depression (clinicaltrials.gov) - Mar 19, 2016
P1/2, N=45, Recruiting, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Trial primary completion date: Feb 2016 --> Nov 2016 Trial primary completion date: Feb 2016 --> Nov 2016
- |||||||||| Trintellix (vortioxetine) / Lundbeck, Takeda
New P3 trial: Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) (clinicaltrials.gov) - Mar 16, 2016
P3, N=750, Not yet recruiting, Sponsor: H. Lundbeck A/S
- |||||||||| Trintellix (vortioxetine) / Lundbeck, Takeda
New P3 trial: Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD) (clinicaltrials.gov) - Mar 16, 2016
P3, N=750, Not yet recruiting, Sponsor: H. Lundbeck A/S
- riluzole / Generic mfg., amiloride hydrochloride / Generic mfg., fluoxetine / Generic mfg.
P2b data, Trial primary completion date: MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (clinicaltrials.gov) - Mar 15, 2016
P2b, N=440, Recruiting, Sponsor: University College, London
Trial primary completion date: Feb 2016 --> Nov 2016 Trial primary completion date: Nov 2017 --> Apr 2018
- fluoxetine / Generic mfg.
Enrollment open: Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF. (clinicaltrials.gov) - Mar 10, 2016
P4, N=45, Recruiting, Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Trial primary completion date: Nov 2017 --> Apr 2018 Not yet recruiting --> Recruiting
- |||| venlafaxine extended release / Generic mfg., fluoxetine / Generic mfg.
Trial completion: Study Evaluating Venlafaxine ER in Recurrent Depression (clinicaltrials.gov) - Feb 27, 2016
P4, N=1096, Completed, Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- | fluoxetine / Generic mfg.
Trial completion: Fluoxetine for Anxious Children (clinicaltrials.gov) - Feb 27, 2016
P3, N=0, Completed, Sponsor: University of Pittsburgh
No longer recruiting --> Completed No longer recruiting --> Completed
- || fluoxetine / Generic mfg.
New P3 trial: EFFECTS: Efficacy of Fluoxetine - a Trial in Stroke (clinicaltrials.gov) - Feb 17, 2016
P3, N=1500, Recruiting, Sponsor: Karolinska Institutet
- fluoxetine / Generic mfg.
Trial termination, Trial primary completion date: EFLUSTIM: "Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke" (clinicaltrials.gov) - Feb 12, 2016
P=N/A, N=6, Terminated, Sponsor: Centre Hospitalier St Anne
No longer recruiting --> Completed Active, not recruiting --> Terminated | Trial primary completion date: Feb 2016 --> Aug 2015; Not enough recruitment
- fluoxetine / Generic mfg.
Enrollment status, HEOR: Comparison of Acupuncture and Fluoxetine on Quality of Life in Menopausal Women (clinicaltrials.gov) - Feb 9, 2016
P=N/A, N=140, Enrolling by invitation, Sponsor: Gonabad University of Medical Sciences
Active, not recruiting --> Terminated | Trial primary completion date: Feb 2016 --> Aug 2015; Not enough recruitment Recruiting --> Enrolling by invitation
- | olanzapine/fluoxetine / Generic mfg., fluoxetine / Generic mfg.
Trial termination: A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression (clinicaltrials.gov) - Feb 9, 2016
P3, N=176, Terminated, Sponsor: Eli Lilly and Company
Recruiting --> Enrolling by invitation Completed --> Terminated; Interim assessment: Lack of efficacy
- fluoxetine / Generic mfg.
Trial initiation date: Acupuncture for Ischemic Post-stroke Depression (clinicaltrials.gov) - Feb 6, 2016
P=N/A, N=208, Not yet recruiting, Sponsor: Menghan Li
Completed --> Terminated; Interim assessment: Lack of efficacy Initiation date: Jul 2015 --> Mar 2016
- fluoxetine / Generic mfg.
Trial initiation date, Trial primary completion date: Fluoxetine Prevention Trial (clinicaltrials.gov) - Feb 5, 2016
P=N/A, N=376, Not yet recruiting, Sponsor: University of California, Los Angeles
Initiation date: Jul 2015 --> Mar 2016 Initiation date: Jun 2015 --> Jun 2018 | Trial primary completion date: Oct 2017 --> Oct 2020
- sertraline / Generic mfg., fluoxetine / Generic mfg., escitalopram / Generic mfg.
Phase classification: ssrifMRI: Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression (clinicaltrials.gov) - Feb 4, 2016
P1, N=98, Completed, Sponsor: University of Pittsburgh
Initiation date: Jun 2015 --> Jun 2018 | Trial primary completion date: Oct 2017 --> Oct 2020 Phase classification: P=N/A --> P1
- fluoxetine / Generic mfg.
Trial primary completion date: Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome (clinicaltrials.gov) - Jan 27, 2016
P3, N=300, Recruiting, Sponsor: Cairo University
Phase classification: P=N/A --> P1 Trial primary completion date: Jul 2016 --> Jul 2017
- fluoxetine / Generic mfg.
Trial completion, Enrollment change: PET Imaging Study of Recovered Anorexics (clinicaltrials.gov) - Jan 16, 2016
P=N/A, N=23, Completed, Sponsor: University of Pittsburgh
Trial primary completion date: Jul 2016 --> Jul 2017 Active, not recruiting --> Completed | N=120 --> 23
- sertraline / Generic mfg., fluoxetine / Generic mfg., escitalopram / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: ssrifMRI: Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression (clinicaltrials.gov) - Jan 16, 2016
P=N/A, N=98, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed | N=120 --> 23 Recruiting --> Completed | N=65 --> 98 | Trial primary completion date: May 2010 --> Jul 2011